Ivabradine in heart failure--no paradigm SHIFT…yet.
Teerlink
John R
JR
School of Medicine, University of California, San Francisco, San Francisco, CA, USA. john.teerlink@ucsf.edu
D000368:Aged; D001552:Benzazepines / Q000494:pharmacology* / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D054143:Heart Failure, Systolic / Q000188:drug therapy* / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects*; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D000077550:Ivabradine; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D013318:Stroke Volume / Q000187:drug effects; D016896:Treatment Outcome
D001552:Benzazepines; D002317:Cardiovascular Agents; D000077550:Ivabradine